EXHIBIT 10.64 ELEVENTH AMENDMENT TO LEASE This Eleventh Amendment to that certain Lease (this "Eleventh Amendment") dated as of the 23 day of April, 1998, between HUB PROPERTIES TRUST, a Maryland real estate investment trust ("LANDLORD") and Corvas...Lease • May 14th, 1998 • Corvas International Inc • Pharmaceutical preparations
RECITALSSettlement Agreement • August 13th, 1999 • Corvas International Inc • Pharmaceutical preparations • California
SECOND AMENDED AND RESTATED PROMISSORY NOTEPromissory Note • November 14th, 2001 • Corvas International Inc • Pharmaceutical preparations • California
EXHIBIT 10.52 August 5, 2002 Kevin Helmbacher, Esq. 232 Pacific View Lane Encinitas, CA 92024 Dear Kevin: As you are aware, Corvas has had to reevaluate its ongoing research and development efforts which has resulted in a Company- wide reduction in...Separation Agreement • November 14th, 2002 • Corvas International Inc • Pharmaceutical preparations • California
UNDERWRITING AGREEMENTUnderwriting Agreement • November 2nd, 2000 • Corvas International Inc • Pharmaceutical preparations • New York
RECITALSCommon Stock Purchase Agreement • November 12th, 1999 • Corvas International Inc • Pharmaceutical preparations • California
AMENDMENT 1 TO DAVID S. KABAKOFF, PH.D./ CORVAS CONSULTING AGREEMENTConsulting Agreement • March 31st, 1997 • Corvas International Inc • Pharmaceutical preparations
EXHIBIT 10.57 KEANE EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT BY AND BETWEEN CORVAS INTERNATIONAL, INC.Employment Agreement • November 14th, 2001 • Corvas International Inc • Pharmaceutical preparations • California
REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT, dated as of October 20, 1999 (this "Agreement"), is made by and among CORVAS INTERNATIONAL, INC., a Delaware corporation (the "COMPANY"), SOFINOV SOCIETE FINANCIERE D'INNOVATION INC.,...Registration Rights Agreement • November 12th, 1999 • Corvas International Inc • Pharmaceutical preparations • California
WARRANT NO. __________Warrant Agreement • November 13th, 1998 • Corvas International Inc • Pharmaceutical preparations • Delaware
WITNESSETH:Lease Amendment • August 11th, 2000 • Corvas International Inc • Pharmaceutical preparations
THIRD AMENDMENT TO AMENDED AND RESTATED SECURED PROMISSORY NOTESecured Promissory Note • November 14th, 2000 • Corvas International Inc • Pharmaceutical preparations
TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SS.SS. 22.80(b)(4), 200.83 AND 240b-2 AMENDMENT AGREEMENT ------------------- This Amendment Agreement ("Amendment") effective as of the last date on the signature page...Collaboration and License Agreement • August 11th, 2000 • Corvas International Inc • Pharmaceutical preparations
June 23, 1999 Mr. Randall E. Woods President and Chief Executive Officer Corvas International, Inc. 3030 Science Park Road San Diego, California 92121 RE: Factor Xa Research Programs Dear Mr. Woods: This "Letter of Agreement" is in reference to the...Letter of Agreement • August 13th, 1999 • Corvas International Inc • Pharmaceutical preparations
AGREEMENTLicense Agreement • August 11th, 2000 • Corvas International Inc • Pharmaceutical preparations
CORVAS INTERNATIONAL, INC. STOCK OPTION AGREEMENT 2000 EQUITY INCENTIVE PLAN CORVAS INTERNATIONAL, INC. (the "Company"), pursuant to its 2000 Equity Incentive Plan (the "2000 Plan"), hereby grants to Optionholder an option to purchase the number of...Stock Option Agreement • March 30th, 2001 • Corvas International Inc • Pharmaceutical preparations
March 30, 2000 Mr. Randall E. Woods President and Chief Executive Officer Corvas International, Inc. 3030 Science Park Road San Diego, California 92121 RE: HCV Research Program Dear Mr. Woods: This is in reference to the License and Collaboration...License and Collaboration Agreement • May 12th, 2000 • Corvas International Inc • Pharmaceutical preparations
This is in reference to the License and Collaboration Agreement by and between Corvas International, Inc. (hereinafter "Corvas") and Schering Corporation and Schering-Plough Ltd. (collectively called "Schering"), effective as of June 11, 1997 (the "Agreement").
EXHIBIT 10.56 COLLABORATIVE AGREEMENTCollaborative Agreement • August 14th, 2001 • Corvas International Inc • Pharmaceutical preparations • Delaware
Exhibit 10.57 TWELFTH AMENDMENT TO LEASE -------------------------- This Twelfth Amendment to that certain lease (this "TWELFTH AMENDMENT") dated as of the 9 day of March, 1999, between HUB PROPERTIES TRUST, a Maryland real estate investment trust...Lease • March 31st, 1999 • Corvas International Inc • Pharmaceutical preparations
AS RIGHTS AGENT RIGHTS AGREEMENTRights Agreement • October 8th, 1997 • Corvas International Inc • Pharmaceutical preparations • Delaware
Exhibit 10.62 [Corvas letterhead] March 23, 1998 John E. Crawford 2547 Caminito La Paz La Jolla, California 92037 Dear John: This letter sets forth the terms and conditions of our agreement (the "Agreement") regarding your resignation from Corvas...Severance Agreement • March 31st, 1998 • Corvas International Inc • Pharmaceutical preparations
EMPLOYMENT AGREEMENT BY AND BETWEENEmployment Agreement • March 31st, 1997 • Corvas International Inc • Pharmaceutical preparations • California
OPTION AGREEMENTOption Agreement • August 13th, 1997 • Corvas International Inc • Pharmaceutical preparations • California
AMENDMENTSettlement Agreement and Mutual General Release • August 13th, 1999 • Corvas International Inc • Pharmaceutical preparations
Corvas letterhead] September 23, 1997 William C. Ripka, Ph.D. 10819 Red Rock Drive San Diego, California 92131 Dear Bill: This letter sets forth the terms and conditions of our agreement (the "Agreement") regarding your retirement from Corvas...Retirement Agreement • November 12th, 1997 • Corvas International Inc • Pharmaceutical preparations
EXHIBIT 10.50 [Pfizer letterhead] John L. LaMattina, Ph.D. Vice President, Pfizer Inc Executive Vice President, PGRD President, Worldwide Research June 13, 2002 George Vlasuk Corvas International Inc. 3030 Science Park Road San Diego, California...License and Development Agreement • August 14th, 2002 • Corvas International Inc • Pharmaceutical preparations
In accordance with Section 18.4 of the License and Development Agreement, dated October 14, 1995 between Corvas International, Inc. and Pfizer Inc, including Pfizer Limited (the " 1995 Agreement"), Pfizer has terminated the development in all indications of Neutrophil Inhibitory Factor and terminates the 1995 Agreement.
RESEARCH AND DEVELOPMENT AGREEMENTResearch and Development • August 13th, 1997 • Corvas International Inc • Pharmaceutical preparations • California
September 8, 1999 Mr. Randall E. Woods President and Chief Executive Officer Corvas International, Inc. 3030 Science Park Road San Diego, California 92121 RE: Factor Xa Research Programs Dear Mr. Woods: This "Letter of Agreement" is to notify you of...Factor Xa Research Program • November 12th, 1999 • Corvas International Inc • Pharmaceutical preparations
EXHIBIT 10.52 SECOND AMENDMENT TO THE CORVAS INTERNATIONAL, INC. 401(K) COMPENSATION DEFERRAL SAVINGS PLAN AND TRUST AGREEMENT The Corvas International, Inc. 401(k) Compensation Deferral Savings Plan and Trust Agreement (the "Plan"), as amended and...401(k) Compensation Deferral Savings Plan Amendment • March 14th, 2003 • Corvas International Inc • Pharmaceutical preparations
January 28, 1997 Howard R. Soule, Ph.D. 1548 Eldon Lane Encinitas, California 92024 Dear Howard: This letter sets forth the terms and conditions of our agreement (the "Agreement") regarding the termination of your employment with Corvas International,...Severance Agreement • March 31st, 1997 • Corvas International Inc • Pharmaceutical preparations • California
Exhibit 10.71 [LETTERHEAD OF SCHERING CORPORATION] October 12, 1998 VIA AIRBORNE EXPRESS Corvas International, Inc. 3030 Science Park Road San Diego, California 92121 Attention: Corporate Secretary Gentlemen: This letter is sent with reference to the...Termination Agreement • November 13th, 1998 • Corvas International Inc • Pharmaceutical preparations
BETWEEN SCHERING-PLOUGH LTD. ANDLicense and Collaboration Agreement • August 13th, 1997 • Corvas International Inc • Pharmaceutical preparations • Delaware
ORTHO-CLINICAL DIAGNOSTICS, INC. U.S. Route 202 Raritan, NJ 08869 June 15, 1998 CORVAS INTERNATIONAL, INC. 3030 Science Road San Diego, CA 92121 RE: Termination of Supply Agreement Ladies and Gentlemen: This letter will confirm our agreement to...Supply Agreement • November 13th, 1998 • Corvas International Inc • Pharmaceutical preparations
This letter will confirm our agreement to terminate that certain Supply Agreement dated June 8, 1992 (the "Supply Agreement") between Corvas International, Inc. ("CORVAS") and Ortho-Clinical Diagnostics, Inc., successor by merger to Ortho Diagnostic Systems Inc. ("OCD") (Capitalized terms used and not otherwise defined herein shall have the meanings given them in the Supply Agreement.) CORVAS and OCD hereby agree that, effective as of the date of this letter, the Supply Agreement shall terminate and all rights and obligations thereunder shall be extinguished; PROVIDED, HOWEVER, that termination of the Supply Agreement shall neither affect the rights and obligations of the parties accrued through June 15, 1998, including, without limitation, the provisions set forth in Section 6 of the Supply Agreement relating to Products manufactured or distributed during the term of the Supply Agreement, nor terminate Sections 12, 13, 15, 16, 18 - 26 of the Supply Agreement.
EXHIBIT 10.69 AGREEMENT FOR CORVAS TO MAINTAIN ANTIBODY AGREEMENTS WHEREAS, Corvas International, Inc. ("Corvas") and The Scripps Research Institute (formerly Scripps Clinic and Research Foundation) ("Scripps") have entered into that certain Research...Agreement for Corvas to Maintain Antibody Agreements • November 13th, 1998 • Corvas International Inc • Pharmaceutical preparations
CORVAS INTERNATIONAL, INC. FIRST AMENDMENT TO RIGHTS AGREEMENTRights Agreement • February 25th, 2003 • Corvas International Inc • Pharmaceutical preparations
THIS FIRST AMENDMENT TO RIGHTS AGREEMENT (this "Amendment") is made as of February 24, 2003 between CORVAS INTERNATIONAL, INC., a Delaware corporation (the "Company"), and AMERICAN STOCK TRANSFER AND TRUST COMPANY (the "Rights Agent").
